Natasha Leskovsek is a partner in the Business Department. She joined the Firm in 2008 and is resident in the Washington, DC office.
Ms. Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on FDA regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies.
Before entering legal practice, Ms. Leskovsek worked as a registered nurse in pediatric oncology research at the National Institutes of Health (NIH) and with adult medical and surgical patients. Ms. Leskovsek worked as a consultant for international pharmaceutical and biotech clients while attending Georgetown University Law Center. Her direct clinical trial experience in nursing and project management offers her a unique perspective in advising clients on the conduct of clinical trials in product development and postmarketing studies. She has authored numerous healthcare and FDA-related publications and regularly speaks on a broad range of FDA regulatory topics for national conferences and meetings.
Ms. Leskovsek received her JD from Georgetown University Law Center in 1996 and her MBA and MPM in 1991 from the University of Maryland, College Park. She received her BSN from University of Maryland, Baltimore in 1989.
Ms. Leskovsek is admitted to practice in the District of Columbia and Maryland and is a member of the Food and Drug Law Institute and the American Health Lawyers Association.
